SOFW SOFWAVE MEDICAL LTD

Sofwave™ Wins 2023 NewBeauty Award For Best Non-Invasive Cellulite Treatment

Sofwave™ Wins 2023 NewBeauty Award For Best Non-Invasive Cellulite Treatment

This year’s award is successive to last year’s recognition as NewBeauty’s winner for “Best in Latest Ultrasound” category

SAN CLEMENTE, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, has been named this year’s NewBeauty Award winner for “Best Noninvasive Cellulite Treatment” category. The 13th Annual NewBeauty Awards tested more than 10,000 products and treatments in the last year with help from top doctors, experts and celebrities in choosing 399 products which stood out from the rest. This year’s award was a follow-up to Sofwave’s recognition in 2022 as NewBeauty’s winner for “” category.

“We are delighted to see Sofwave’s new indication for our latest game-changing ultrasound technology recognized by industry. To be voted best-in-class in an awards category two years in a row, amongst a field of over 10,000 products annually, is truly an honor,” said Louis Scafuri, CEO of Sofwave Medical. “Additionally, with over 50,000 pulse treatments conducted in 2022, we are proud to see both practitioners, patients and the media alike embrace SUPERB™ treatments. With this in mind, we are even more excited for what the new year will bring!”

Gilly Munavalli, MD, a board-certified dermatologist and participant in Sofwave’s cellulite clinical trials noted, “Sofwave has proven to be successful in the treatment of cellulite. Sofwave generates high-frequency ultrasonic pulses that elevate the temperature in the dermis layer in order to cause controlled isolated areas of thermal damage. The healing process that follows generates the growth of elastin and collagen fibers, which cause the skin to tighten and improve skin laxity, which leads to the improvement of the appearance of cellulite.”

For a complete list of NewBeauty’s 2023 Awards Winners please visit: .

About Sofwave Medical

 has implemented an innovative approach to wrinkle reduction lifting and cellulite using proprietary breakthrough technology. SUPERB™, Synchronous Ultrasound Parallel Beam technology is FDA-cleared head to improve facial lines and wrinkles, lift the eyebrow, and lift lax submental (beneath the chin) and neck tissue; which can also affect the appearance of lax tissue in the submental and neck regions and for short-term improvement in the appearance of cellulite providing physicians with smart yet simple, effective, and safe aesthetic solutions for their patients.

Contact: 

Investor Contact:

Brian Ritchie

LifeSci Advisors LLC

(212) 915-2578



EN
30/03/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SOFWAVE MEDICAL LTD

 PRESS RELEASE

Sofwave to Participate in 10th Annual Needham Virtual MedTech & Diagno...

Sofwave to Participate in 10th Annual Needham Virtual MedTech & Diagnostics Conference SAN CLEMENTE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the 10th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference on August 11 – 12, 2025. About Sofwave Medical has implemented an innovative approach to wrinkle reducti...

 PRESS RELEASE

Sofwave Medical Reports Record Second Quarter and First Half 2025 Fina...

Sofwave Medical Reports Record Second Quarter and First Half 2025 Financial Results and Business Highlights • Quarterly record revenue in Q2 of $21M, +43% year-over-year growth; IFRS gross margin of 75.5% • Second quarter pulse recurring revenue of $9.2M, +53% year-over-year growth • First half revenue of $37.6M, +35% year-over-year growth; IFRS gross margin of 75.9% • Generated $3.6M in cash in the second quarter • Positive first half and second quarter IFRS and Non-IFRS operating and net income vs first half loss in the same year ago period • Over 600,000 treatments completed since i...

 PRESS RELEASE

Sofwave to Participate in Jefferies Global Healthcare Conference

Sofwave to Participate in Jefferies Global Healthcare Conference SAN CLEMENTE, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW),  an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Assaf Korner, Chief Financial Officer, will provide a corporate overview and participate in one-on-one investor meetings at the Jefferies Global Healthcare Conference, to be held in New York from June 3-5, 2025. Jefferies Global Healthcare ConferencePresentation Format: Corporate overviewPresentat...

 PRESS RELEASE

Sofwave Medical Reports First Quarter Fiscal 2025 Financial Results an...

Sofwave Medical Reports First Quarter Fiscal 2025 Financial Results and Business Highlights — First quarter revenue of $16.7M, +26% year-over-year growth; IFRS gross margin of 76.3%— First quarter pulse recurring revenue of $7.0M, +49% year-over-year growth— IFRS and non-IFRS operating loss of -$1M and -$0.2M, respectively SAN CLEMENTE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported financial results for the first quarter of fiscal year 2025, for th...

 PRESS RELEASE

Sofwave’s liftHD Body Contouring Applicator to Debut at the 44th Annua...

Sofwave’s liftHD Body Contouring Applicator to Debut at the 44th Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS) 2025 Launch of the liftHD body applicator provides opportunity for next generation non-invasive aesthetic body treatments which improve cellulite and skin laxity appearance in order to achieve SUPERB results beyond the face Four abstract poster presentations highlighting clinical applications and results of Sofwave’s SUPERB™ non-invasive medical aesthetic technology will also be on exhibit SAN CLEMENTE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch